$49.00
0.15[0.31%]
At close: Apr 19
$49.00
0[0.00%]
After Hours: 7:03PM EDT
Janux Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Janux Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PM | JANX | Q1 | -$0.42 | -$0.36 | — | — | $2.05M | $580.00K | — | — | Get Alert |
03/08/2024 | PM | JANX | Q4 | -$0.39 | -$0.40 | -$0.25 | 37.50% | $2.85M | $750.00K | $2.46M | 228.13% | Get Alert |
11/07/2023 | PM | JANX | Q3 | -$0.40 | -$0.47 | -$0.25 | 46.81% | $1.81M | $850.00K | $2.52M | 196.12% | Get Alert |
08/08/2023 | PM | JANX | Q2 | -$0.41 | -$0.52 | -$0.42 | 19.23% | $2.37M | $870.00K | $1.06M | 21.49% | Get Alert |
05/09/2023 | PM | JANX | Q1 | -$0.32 | -$0.49 | -$0.42 | 14.29% | $1.59M | $670.00K | $2.05M | 205.67% | Get Alert |
03/10/2023 | PM | JANX | Q4 | -$0.33 | -$0.49 | -$0.39 | 20.41% | $1.62M | $790.00K | $2.85M | 260.13% | Get Alert |
11/10/2022 | PM | JANX | Q3 | -$0.26 | -$0.49 | -$0.40 | 18.37% | $1.16M | $740.00K | $1.81M | 145.00% | Get Alert |
08/09/2022 | PM | JANX | Q2 | -$0.62 | -$0.37 | -$0.41 | -10.81% | $482.00K | $850.00K | $2.37M | 178.24% | Get Alert |
05/10/2022 | PM | JANX | Q1 | -$2.06 | -$0.37 | -$0.32 | 13.51% | $380.00K | $820.00K | $1.59M | 93.78% | Get Alert |
03/18/2022 | PM | JANX | Q4 | -$1.65 | -$0.31 | -$0.33 | -6.45% | — | — | $1.62M | — | Get Alert |
11/09/2021 | PM | JANX | Q3 | -$1.33 | -$0.18 | -$0.26 | -44.44% | — | $130.00K | $1.16M | 791.54% | Get Alert |
08/10/2021 | PM | JANX | Q2 | -$2.76 | — | -$0.62 | — | — | — | $482.00K | — | Get Alert |
Janux Therapeutics (JANX) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 8, 2024 for Q4.
The Actual EPS was $-0.25, which beat the estimate of $-0.40.
The Actual Revenue was $2.5M, which beat the estimate of $750K.
Browse earnings estimates, EPS, and revenue on all stocks.